Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group.
Finnes HD, Child B, DeFrates S, Kinsman K, Thorne A, Lentz S, Lockhorst R, Murphy J, Urmanski A, Amin S, Barr H, Baviskar S, Beckman C, Chow N, Derba M, Erickson M, Hennes E, Heisey H, Lau R, Limvorasak S, Luckritz T, Mays T, Nzelibe CN, Romanowski T, Smith C, Tesoro D, Toeniskoetter K, Voytilla K. Finnes HD, et al. Among authors: limvorasak s. Am J Health Syst Pharm. 2023 Jan 1;80(1):e67-e73. doi: 10.1093/ajhp/zxac267. Am J Health Syst Pharm. 2023. PMID: 36200957 Free PMC article. No abstract available.
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
Surati M, Robinson M, Nandi S, Faoro L, Demchuk C, Rolle CE, Kanteti R, Ferguson BD, Hasina R, Gangadhar TC, Salama AK, Arif Q, Kirchner C, Mendonca E, Campbell N, Limvorasak S, Villaflor V, Hensing TA, Krausz T, Vokes EE, Husain AN, Ferguson MK, Karrison TG, Salgia R. Surati M, et al. Among authors: limvorasak s. J Clin Bioinforma. 2011 Feb 28;1(8):1-11. doi: 10.1186/2043-9113-1-8. J Clin Bioinforma. 2011. PMID: 21603121 Free PMC article.
Kinase inhibitors in prostate cancer.
Limvorasak S, Posadas EM. Limvorasak S, et al. Anticancer Agents Med Chem. 2009 Dec;9(10):1089-104. doi: 10.2174/187152009789735080. Anticancer Agents Med Chem. 2009. PMID: 19925393 Review.
Targeted therapies for renal cell carcinoma.
Posadas EM, Limvorasak S, Figlin RA. Posadas EM, et al. Among authors: limvorasak s. Nat Rev Nephrol. 2017 Aug;13(8):496-511. doi: 10.1038/nrneph.2017.82. Epub 2017 Jul 10. Nat Rev Nephrol. 2017. PMID: 28691713 Review.
Targeting angiogenesis in renal cell carcinoma.
Posadas EM, Limvorasak S, Sharma S, Figlin RA. Posadas EM, et al. Among authors: limvorasak s. Expert Opin Pharmacother. 2013 Nov;14(16):2221-36. doi: 10.1517/14656566.2013.832202. Epub 2013 Aug 28. Expert Opin Pharmacother. 2013. PMID: 23984807 Review.
Third-Line Treatment Options for Kidney Cancer.
Posadas EM, Limvorasak S, Figlin RA. Posadas EM, et al. Among authors: limvorasak s. Oncology (Williston Park). 2016 Sep 15;30(9):813-5. Oncology (Williston Park). 2016. PMID: 27633411 Free article. No abstract available.
Pazopanib: therapeutic developments.
Limvorasak S, Posadas EM. Limvorasak S, et al. Expert Opin Pharmacother. 2009 Dec;10(18):3091-102. doi: 10.1517/14656560903436493. Expert Opin Pharmacother. 2009. PMID: 19954277 Review.